Overcoming Solid Tumor Challenges with ARTEMIS® Antibody Redirected T-Cell Therapy
Time: 2:45 pm
day: Bootcamp Day
Details:
- Designing ARTEMIS® Antibody TCR (AbTCR) T-cells to address the major hurdles in treating solid tumor
- Infiltrating into solid tumor under immunosuppressive microenvironment
- Targeting Alpha-fetoprotein (AFP) and Glypican 3 (GPC3) in advanced hepatocellular carcinoma (HCC)
- Demonstrating superior safety and efficacy profile of ARTEMIS® T-cells
